

Core Advantages
Currently, blood-based NIPT offers the highest level of performance for aneuploidy screening but it is inherently limited by relying on measuring low-abundance circulating DNA fragments. In contrast, Cradle’s patented technology isolates and utilizes intact cells at high purity leading to the following core advantages:
- Earliest prenatal testing available
- Highest accuracy in a non-invasive test
- No patient limitations
- Comprehensive genome analysis
- Future testing for pregnancy complications
Our Lab Process

Cell Isolation
Fetal EVT cells are captured and purified using
a proprietary magnetic separation process

Fetal DNA Purification
High purity DNA is extracted from collected fetal EVT cells

Comprehensive Genome Analysis
Fetal DNA is analyzed on a genome sequencer

Interpretation and Clinical Reporting
Clinical results are provided in an intuitive, user-friendly report